Page 269 - Pagetit
P. 269

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                     • Substance dependence is not a failure of will or of strength of character
                        but a medical disorder that could affect any human being. Dependence
                        is a chronic and relapsing disorder, often co-occurring with other
                        physical and mental conditions.
                     • There is significant comorbidity of substance dependence with various
                        other mental illnesses; assessment, treatment and research would be
                        most effective if an integrated approach were adopted. Treatment and
                        prevention insights from other mental illnesses or substance
                        dependence can be used to inform treatment and prevention strategies
                        in the domain of the other. Attention to comorbidity of substance use
                        disorders and other mental disorders is thus required as an element of
                        good practice in treating or intervening in either mental illness or
                        substance dependence.

                     • Treatment for substance dependence is not only aimed at stopping drug
                        use—it is a therapeutic process that involves behaviour changes,
                        psychosocial interventions and often, the use of substitute psychotropic
                        drugs. Dependence can be treated and managed cost-effectively, saving
                        lives, improving the health of affected individuals and their families,
                        and reducing costs to society.
                     • Treatment must be accessible to all in need. Effective interventions exist
                        and can be integrated into health systems, including primary health
                        care. The health care sector needs to provide the most cost-effective
                        treatments.
                     • One of the main barriers to treatment and care of people with substance
                        dependence and related problems is the stigma and discrimination
                        against them. Regardless of the level of substance use and which
                        substance an individual takes, they have the same rights to health,
                        education, work opportunities and reintegration into society, as does
                        any other individual.
                     • Investments in neuroscience research must continue and expand to
                        include investments in social science, prevention, treatment and policy
                        research. The reduction in the burden from substance use and related
                        disorders must rely on evidence-based policies and programmes which
                        are the result of research and its application.


                   Conclusion
                   This report has summarized the advances in our understanding of the
                   neuroscience of psychoactive substance use and dependence in recent
                   decades, and has considered some of the ethical issues which are connected
                   with these advances. The developments in neuroscience have greatly
                   increased our knowledge about substance use and dependence, and the new


                                                  248




          Chapter_8                248                             19.1.2004, 11:51
   264   265   266   267   268   269   270   271   272   273   274